VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Zebra 365 who wrote (3798)	12/17/1997 8:54:00 AM
From: blankmind	Read Replies (1) of 23519

-- Somehting a little more relevant: 1. CNTO is going to be hit hard today. Earnings are projected to be $.42 in '98. -- VS - $1.40 or so for VVUS. 2. CNTO closed at 37 7/8 yesterday. 3. CNTO's ytd high is 53. 4. With this bad news, does anyone think that CNTO will really come down to the $10 level - where VVUS is? 5. My point, is that the reaction to VVUS's shortfall has been overdone. Stock price will rebound with a vengeance. << Genesis Merchant Group Securities analyst Deepa Pakianathan, Ph.D., downgraded her recommendation on Centocor, Inc. (Nasdaq: CNTO - news) to hold from strong buy and anticipates lowering her 1998 estimates significantly. Pakianathan cited several factors that led to the downgrade, including: uncertainty surrounding the company's ability to sign a marketing partner for Avakine, potential lower than expected revenue growth for ReoPro and increased expenses. Based on an early analysis ''we estimate earnings of $0.02 per share for the fourth quarter 1997 and $0.38 to $0.42 per share for 1998,'' Pakianathan said. >>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next